CXCL13 and CXCL9 CSF Levels in Central Nervous System Lymphoma—Diagnostic, Therapeutic, and Prognostic Relevance

CXCL13 and CXCL9 CSF Levels in Central Nervous System Lymphoma—Diagnostic, Therapeutic, and Prognostic Relevance

Background: Diagnostic delay and neurologic deterioration are still a problem for the treatment of rapidly progressing CNS lymphoma (CNSL); there is an unmet need for a diagnostic test with a high diagnostic yield and limited risk, minimizing the time to the initiation of effective treatment.Methods...

Full description

Bibliographic Details
Main Authors: Ilias Masouris, Kirsi Manz, Markus Pfirrmann, Martin Dreyling, Barbara Angele, Andreas Straube, Sigrid Langer, Marion Huber, Uwe Koedel, Louisa Von Baumgarten
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Neurology
Subjects:
CNS lymphoma
cerebrospical fluid
biomarker
CXCL13 chemokine
CXCL9
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2021.654543/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2021.654543/full

Similar Items